News
FDA GRANTS CLEARANCE FOR THE HAIRMAX DUAL 12 MODEL FOR THE TREATMENT OF FEMALE PATTERN HAIR LOSS.
Press Release (PDF) Lexington International, LLC is pleased to announce that it has received FDA Marketing Clearance for the HairMax Dual 12 home-use laser phototherapy device for hereditary hair loss in females. Boca Raton, FL (August 24, 2011) - Boca Raton, FL - Lexington Int’l is proud to announce that the FDA has granted Marketing Clearance for their new model of a home-use laser phototherapy device, the HairMax Dual 12....
NEW FDA CLEARANCE FOR THE HAIRMAX LASERCOMB FILLS AN UNMET NEED OF PROVIDING AN EFFECTIVE, NON-DRUG HOME-USE DEVICE FOR TREATING HAIR LOSS.
Press Release (PDF) Boca Raton, FL. (Oct 19, 2011) - Lexington International, LLC, is pleased to announce that the company has received FDA 510(k) #K112524 Marketing Clearance for two new models of the HairMax LaserComb®, laser phototherapy medical device for the treatment of hereditary hair loss in women. FDA Clearance Letter Link:http://hairmax.com/mediakit/docs/FDA_Clearance_adv7_pro12.pdf Hereditary hair loss is a devastating condition affecting over 30 million women in the United States. Until recently,...
